Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate

BACKGROUND: All of the components of Metabolic syndrome (MetS) have been regarded as risk factors for coronary artery disease (CAD). Early detection of CAD in asymptomatic patients with MetS remains a challenge. Cystatin C,which has been proposed as a novel marker of renal dysfunction,is correlated...

Descripción completa

Detalles Bibliográficos
Autores principales: Qing, Xie, Furong, Wang, Yunxia, Liu, Jian, Zhang, Xuping, Wang, Ling, Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473246/
https://www.ncbi.nlm.nih.gov/pubmed/22978689
http://dx.doi.org/10.1186/1475-2840-11-108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473246/
https://www.ncbi.nlm.nih.gov/pubmed/22978689
http://dx.doi.org/10.1186/1475-2840-11-108

Ejemplares similares